: , , As hopeful as this is, a few big questions remain, especially if we care about equity and not just headlines: - Will oral GLP-1s actually be covered by insurers and employers as long term therapy, instead of short weight loss sprints followed by predictable regain - How will pricing and step edits work when a patient has already been on an injectable for more than a year - Will these trials and future studies meaningfully include the diverse, underrepresented communities that carry a disproportionate burden of obesity, sleep apnea, and cardiometabolic disease : - Set expectations early: discuss obesity as chronic disease, and proactively plan for maintenance before stopping anything
What is the active ingredient
Cast Your Votes Vote for one or many peptides
doi: 10.1002/(SICI)1097-0231(19960331)10:5 3.0.CO;2-Q
Safe and Well-Tolerated for Most Users As a naturally occurring compound already found in the body, GHK-Cu is considered very safe and non-toxic
10.1089/lrb.2019.0072 40 FarrO
